Evidence mapPaperPMID 41537151Full record

ReviewRegenerative therapy2026

Best evidence summary for platelet-rich plasma treatment of chronic wounds.

Xinru Zhang, Xingxing Zhang, Luxin Wang, Li Zhen, Meiyan Lin, Yanan Li, Lihong Gong, Haiting Zeng, Weiqing Ruan, Mulan Zhu

Abstract readReview
In one paragraph

Review in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xinru ZhangHuiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Xingxing ZhangDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Luxin WangSchool of Nursing and Health, Zhengzhou University, Zhengzhou, China.
Li ZhenDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Meiyan LinSchool of Nursing, Southern Medical University, Guangzhou, China.
Yanan LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Lihong GongDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Haiting ZengDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Weiqing RuanHuiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Mulan ZhuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To summarize the best evidence for platelet-rich plasma therapy in chronic wounds, providing an evidence-based foundation for standardizing its clinical practice. Methods: Guided by the "6S" evidence pyramid model, we systematically searched 12 databases including Cochrane Library and Pubmed, 9 guideline websites including Guidelines International Network (GIN) and National Institute for Health and Clinical Excellence (NICE), and 10 professional websites including World Union of Wound Healing Societies (WUWHS), for relevant evidence from the establishment of the database to May 1, 2025. Two researchers independently conducted quality assessment, evidence extraction, and integration of the included literature. Results: A total of 17 articles were included, comprising 3 guidelines, 5 expert consensus statements, and 9 systematic reviews. The evidence was categorized into six key treatment domains: application principles, indications and contraindications, pre-treatment preparations, treatment protocols, efficacy monitoring, and management strategies. 27 individual recommendations were derived from these categories. Conclusion: Platelet-rich plasma therapy can be used as an adjunctive treatment for the management of chronic wounds. Clinicians and wound care specialists should thoroughly assess the applicability and timing of platelet-rich plasma, considering the specific clinical context, and combine it with the patient's physical condition and preferences for clinical application, promoting chronic wound healing and reducing the global disease burden of chronic wounds.

Indexed as

Chronic woundsEvidence-based nursingEvidence summaryPlatelet-rich plasma

Identifiers

PMID41537151
PMCPMC12795992

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.